Association of β-amyloid 40 and 42 With Prediabetes

计划入组 1,442 人 · 首次发布于 2021 年 9 月 5 日

Amyloid-β Clearance Mechanisms in Alzheimer's Disease

计划入组 60 人 · 首次发布于 2021 年 9 月 28 日

tACS for Amyloid-β Reduction in Alzheimer's Disease

计划入组 17 人 · 首次发布于 2017 年 9 月 21 日

Target Amyloid-β (Wavebreak Therapeutics)

NU-700

SBL-PX1-42

NHI-1

United States

Level 42 AI, Inc.

United States

Xi'an No.1 Hospital

China

Spear Bio and Beckman Coulter Receive FDA Breakthrough Device Designations for Alzheimer's Blood Tests

Elevated Plasma Amyloid-β 1-40 Linked to Higher Postoperative Delirium Risk After Cardiac Surgery

Scientists' Choice Awards 2026 Announced at ADLM: Thermo Fisher, Mindray, Siemens Healthineers, and Danaher Among Winners